Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Latex sensitization and allergy in children with spinal dysraphism: A meta-analysis.

Created on 05 Oct 2026

Authors

Isaac Chung, Nikhil Manoj, Khalida Ahmad, Ece Nur Çinar, Michael R Perkin, Anna Bridgens, Yael Gelfer

Published in

The journal of spinal cord medicine. Pages 1-12. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

Children with Spinal Dysraphism have historically demonstrated a higher prevalence of latex allergy which resulted in efforts to establish latex-free environments for these children. Whether this has reduced latex sensitization and allergy prevalence is uncertain.
This systematic review evaluates and summarizes the current evidence of the prevalence of latex allergy in children with spinal dysraphism.
MEDLINE, Embase, and PubMed databases were searched for studies investigating the prevalence of latex sensitisation and allergy in patients with spina dysraphism from inception until May 2025. An a priori protocol was registered on PROSPERO (CRD42024568889). Baseline characteristics and prevalence of positive IgE, positive skin prick, and allergy to latex were double-screened and extracted independently. Meta-analysis was performed, pooling the prevalence rate under a random effects model.
Nineteen studies were included in the meta-analysis. Latex sensitization was common: 20% on specific IgE testing (95% CI 11% - 34%, I2 = 87%) and 21% on skin prick testing (95% CI 13% - 32%, I2 = 67%). Latex allergy was present in 6% (95% CI 2% - 17%, I2 = 88%). Latex sensitization and allergy rates appear to be decreasing over time, although the trends were not statistically significant.
These findings highlight the persistently high prevalence of latex sensitization and allergy in children with spinal dysraphism. The absence of recent studies and the widespread introduction of latex-free products underscore the need for up-to-date prevalence data. Establishing a dedicated registry would help determine current prevalence rates.

PMID:
42831677
Bibliographic data and abstract were imported from PubMed on 05 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement